SLC1A5, FTH1, FTL, HSPB1, NCOA4, SLC11A2, ZEB1, and TFRC genes were also differentially expressed in GBM patients with and without IDH mutation in the CGGA dataset (Figure 2D). This evidence concerns the gene SLC11A2 and glioblastoma.